Search Results
Results found for "GPCR data platform"
- Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
$5 Million Pre-series A Round to Accelerate Commercialization of Ultrahigh Throughput Drug Discovery Platform The proceeds will be used to further build the company’s discovery platform and operations. Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like These molecules are then evaluated at unprecedented speed and scale on hundreds of GPCR targets simultaneously Read more at the source #DrGPCR #GPCR #IndustryNews
- Platelets in the NETworks interweaving inflammation and thrombosis
Read more at the source #DrGPCR #GPCR #IndustryNews
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Changes to Drive the Company Through the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based drug design platform and enhancing translational medicine capabilities • ‘Venture-like Read more at the source #DrGPCR #GPCR #IndustryNews
- Effects of Small Molecule Ligands on ACKR3 Receptors
Read more at the source #DrGPCR #GPCR #IndustryNews
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
Read more at the source #DrGPCR #GPCR #IndustryNews
- Michel Bouvier appointed Knight of the Ordre national du Québec
Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Presents Clinical And Research Results At ENDO 2022
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex raises $4.2 million in equity financing
Unregistered Warrants have an exercise price of $1.90 per ADS, will become exercisable in 60 days after their date of issuance and will expire five years from their date of issuance. " Read more at the source #DrGPCR #GPCR #IndustryNews
- ShouTi Pharma CEO Dr. Raymond Stevens was interviewed by Moira Gunn of the NPR TechNation podcast
April 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical "Submission supported by data Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
Series of Potent and Selective Compounds Identified Using Proprietary Allosteric Modulator Screening Platform Read more at the source #DrGPCR #GPCR #IndustryNews
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Kenakin’s latest lecture delivers a wake-up call for pharmacologists interpreting allosteric binding data If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is If you’re still using orthosteric assumptions to interpret allosteric binding data, you're likely missing Subscribe to The Kenakin Brief today ➤ #AllostericPharmacology #GPCR #BindingVsFunction #ReceptorPharmacology
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
– Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs pharmacokinetics of CFTX-1554 in healthy subjects (NCT05260658). " Read more at the source #DrGPCR #GPCR
- John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
control neuropsychiatric symptoms in conditions such as schizophrenia. " Read more at the source #DrGPCR #GPCR
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies against GPCR sophisticated bioinformatics expertise with Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR targets Tokyo, Japan and Cambridge, UK, 16 enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Biotechnology, a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs ) with a novel drug modality, proven discovery platform and best-in-class molecules, today announced OB-004 is a GPCR targeted protein analog of CCL2 that targets the CCR2 receptor. Read more at the source #DrGPCR #GPCR #IndustryNews
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
December 2021 "30/11/2021 Confo will work together with Regeneron to apply its GPCR drug discovery platform entered into a collaborative agreement with Regeneron Pharmaceuticals, Inc. whereby Confo’s technology platform , which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G protein-coupled enabling the discovery of novel therapeutic antibody drug candidates. " Read more at the source #DrGPCR #GPCR
- Sosei Heptares reported its FY2021 financial result and provided an update on operational activities
February 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- How Fast Does a Drug Work?
delivers exclusive, real-world insight designed to equip you to move beyond surface-level affinity data operational clarity and avoid wasted effort ✅ The ability to reduce cycle times by recognizing when your data practical kinetic expertise—crafted to help drug hunters reduce wasted effort and move faster from data guidance on when to look deeper and how to extract meaningful, operational insight from your kinetic data s Corner ______ #DrugDiscovery #Pharmacology #DrugKinetics #PipelineEfficiency #PharmaInnovation #GPCR
- ShouTi Pharma has a brand new website
Read more at the source #DrGPCR #GPCR #IndustryNews
